Eton Pharmaceuticals, Inc.(ETON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ETON Eton Pharmaceuticals, Inc.

Market Closed 12-12 16:00:00 EST

16.70

-0.18

-1.07%

盘后16.70

+0.000.00%

16:10 EST

High17.19	Low16.65	Vol279.67K
Open17.02	D1 Closing16.88	Amplitude3.20%
Mkt Cap447.85M	Tradable Cap303.01M	Total Shares26.82M
T/O4.72M	T/O Rate1.54%	Tradable Shares18.14M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ETON","market":"US","secType":"STK","nameCN":"Eton Pharmaceuticals, Inc.","latestPrice":16.7,"timestamp":1765573200000,"preClose":16.88,"halted":0,"volume":279672,"hourTrading":{"tag":"盘后","latestPrice":16.7,"preClose":16.7,"latestTime":"16:10 EST","volume":6482,"amount":108249.4,"timestamp":1765573803955},"delay":0,"floatShares":18144207,"shares":26817535,"eps":-0.258783,"marketStatus":"Market Closed","change":-0.18,"latestTime":"12-12 16:00:00 EST","open":17.02,"high":17.19,"low":16.65,"amount":4720465.80005,"amplitude":0.031991,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.258783,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1541739600000,"exchange":"NASDAQ","adjPreClose":16.88,"postHourTrading":{"tag":"盘后","latestPrice":16.7,"preClose":16.7,"latestTime":"16:10 EST","volume":6482,"amount":108249.4,"timestamp":1765573803955},"volumeRatio":1.265559751802115,"impliedVol":0.7107,"impliedVolPercentile":0.636},"requestUrl":"/m/hq/s/ETON/wiki","defaultTab":"wiki","newsList":[{"id":"2584966895","title":"Eton Pharmaceuticals Issues Amended Financial Report on Acquired Increlex Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2584966895","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584966895?lang=en_us&edition=fundamental","pubTime":"2025-11-19 05:17","pubTimestamp":1763500634,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals Inc. has filed an amendment to its Form 8-K, providing audited and unaudited abbreviated financial statements related to its acquired INCRELEX product for the years ended December 31, 2023 and 2022, and for the nine months ended September 30, 2024 and 2023. The amendment includes a report from independent certified public accountants and notes that the financial statements are prepared specifically for SEC compliance and are not a complete presentation of the product line's financials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Se","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL3Hx3GW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"gpt_icon":0},{"id":"1140705902","title":"Eton Pharmaceuticals Q3 2025 Earnings Call Summary and Q&A Highlights: Record Revenue Growth and Strategic Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1140705902","media":"Earnings Call","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140705902?lang=en_us&edition=fundamental","pubTime":"2025-11-09 13:21","pubTimestamp":1762665677,"startTime":"0","endTime":"0","summary":"[Management View]Eton Pharmaceuticals reported record quarterly revenue of $22.5 million in Q3 2025, marking a 129% year-over-year increase and a 19% sequential growth. Key drivers included Alkindi...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON"],"gpt_icon":0},{"id":"2582893778","title":"Eton Pharma (ETON) Q3 2025 Earnings Transcript","url":"https://stock-news.laohu8.com/highlight/detail?id=2582893778","media":"Motley Fool Transcribing","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582893778?lang=en_us&edition=fundamental","pubTime":"2025-11-09 13:17","pubTimestamp":1762665460,"startTime":"0","endTime":"0","summary":"DATEThursday, November 6, 2025 at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Sean BrynjelsenChief Financial Officer — James GruberExecutive Vice President, Corporate Development — David KrempaNeed a quote from a Motley Fool analyst?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_motley_transcript","url":"https://www.fool.com/earnings/call-transcripts/2025/11/09/eton-pharma-eton-q3-2025-earnings-transcript/","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/earnings/call-transcripts/2025/11/09/eton-pharma-eton-q3-2025-earnings-transcript/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_motley_transcript","symbols":["ETON"],"gpt_icon":0},{"id":"2581048431","title":"Eton Pharmaceuticals Q3 Adj. EPS $0.04 Misses $0.09 Estimate, Sales $22.459M Beat $20.474M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581048431","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581048431?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:22","pubTimestamp":1762464131,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.09 by 55.56 percent. This is a 100 percent increase over earnings of $0.02 per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48704368/eton-pharmaceuticals-q3-adj-eps-0-04-misses-0-09-estimate-sales-22-459m-beat-20-474m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Eton Pharmaceuticals Q3 Adj. EPS $0.04 Misses $0.09 Estimate, Sales $22.459M Beat $20.474M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"gpt_icon":0},{"id":"2581010898","title":"BRIEF-Eton Pharmaceuticals Q3 Net Income USD -1.927 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581010898","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581010898?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:06","pubTimestamp":1762463163,"startTime":"0","endTime":"0","summary":"BRIEF-Eton Pharmaceuticals Q3 Net Income USD -1.927 Million\n\n\nNov 06 (Reuters) - Eton Pharmaceuticals Q3 EPS USD -0.07.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nPLX2494B9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"gpt_icon":0},{"id":"2581904871","title":"Eton Pharmaceuticals Q3 Adjusted EPS USD 0.04","url":"https://stock-news.laohu8.com/highlight/detail?id=2581904871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581904871?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:05","pubTimestamp":1762463118,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nPLX2494B9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ETON"],"gpt_icon":0},{"id":"2581017577","title":"Eton Pharmaceuticals Q3 EPS USD -0.07","url":"https://stock-news.laohu8.com/highlight/detail?id=2581017577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581017577?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:05","pubTimestamp":1762463118,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nPLX2494B9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETON","BK4007"],"gpt_icon":0},{"id":"2579865135","title":"3 Growth Companies With Insider Ownership Up To 31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579865135","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579865135?lang=en_us&edition=fundamental","pubTime":"2025-10-30 01:05","pubTimestamp":1761757554,"startTime":"0","endTime":"0","summary":"As major stock indexes in the United States continue to reach new heights, driven by significant developments such as Nvidia's landmark $5 trillion market cap and anticipation around Federal Reserve decisions, investors are keenly watching for growth opportunities. In this buoyant market environment, identifying growth companies with substantial insider ownership can provide insights into potential confidence from those closest to the company.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eton/eton-pharmaceuticals/news/3-growth-companies-with-insider-ownership-up-to-31-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eton/eton-pharmaceuticals/news/3-growth-companies-with-insider-ownership-up-to-31-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CRDO","IE00BZ9MQY76.HKD","LU0056508442.USD","LU0594300179.USD","SMTI","BK4561","BK4091","LU2360107671.USD","BK4177","BK7067","BK4007","LU2931357623.SGD","LU2063271972.USD","ANTA","IE00B19Z9Z06.USD","BK4166","CELH","ATAT","LU1861215975.USD","BK4585","BK4539","LU1861220033.SGD","LU0353189680.USD","BK4588","LU2290526834.HKD","LU2065731478.USD","LU0594300419.USD","BK4141","LU0605514214.HKD","PROP","LU2211817866.USD","ETON","ARX.AU","ARX","NIU.AU","LU0053671581.USD","BK4023","NIU","BK4142","LU1861220207.SGD","BK4198","BK4608","BK4096","FTCI","LU0231459107.USD","LU0650527681.SGD","LU2360107168.USD"],"gpt_icon":1},{"id":"2561484293","title":"CFO James R. Gruber Reports Disposal of Common Shares of Eton Pharmaceuticals Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2561484293","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561484293?lang=en_us&edition=fundamental","pubTime":"2025-08-21 05:14","pubTimestamp":1755724479,"startTime":"0","endTime":"0","summary":"James R. Gruber, Chief Financial Officer of Eton Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 20, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL8qXsxv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"gpt_icon":0},{"id":"2557859930","title":"Eton Pharmaceuticals Q2 Net Income USD -2.585 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557859930","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557859930?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:23","pubTimestamp":1754598187,"startTime":"0","endTime":"0","summary":"Aug 07 (Reuters) - Eton Pharmaceuticals Q2 basic EPS USD -0.1.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 07-AUG-202520:05:52.6 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nRSD7KZBCW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"gpt_icon":0},{"id":"2557596339","title":"Eton Pharmaceuticals Q2 Adj. EPS $(0.10) Misses $(0.05) Estimate, Sales $18.93M Beat $16.60M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557596339","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557596339?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:06","pubTimestamp":1754597168,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.05) by 88.68 percent. This is a 16.67 percent increase over losses of $(0.12) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46979272/eton-pharmaceuticals-q2-adj-eps-0-10-misses-0-05-estimate-sales-18-93m-beat-16-60m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Eton Pharmaceuticals Q2 Adj. EPS $(0.10) Misses $(0.05) Estimate, Sales $18.93M Beat $16.60M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON"],"gpt_icon":0},{"id":"2557599363","title":"Eton Pharmaceuticals Inc - Projects $80 Mln Annual Revenue Run Rate in Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=2557599363","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557599363?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:05","pubTimestamp":1754597107,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX60315C:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETON","BK4007"],"gpt_icon":0},{"id":"2557599349","title":"Eton Pharmaceuticals Inc  Q2 REV View $16.7 Mln -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2557599349","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557599349?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:05","pubTimestamp":1754597107,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX60315C:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETON","BK4007"],"gpt_icon":0},{"id":"2557599339","title":"Eton Pharmaceuticals Q2 Revenue USD 18.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557599339","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557599339?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:05","pubTimestamp":1754597107,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX60315C:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETON","BK4007"],"gpt_icon":0},{"id":"2557131440","title":"Eton Pharmaceuticals Inc  expected to post a loss of 4 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2557131440","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557131440?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:55","pubTimestamp":1754427305,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals Inc  expected to post a loss of4cents a share - Earnings Preview Eton Pharmaceuticals Inc ETON.OQ ETON.O is expected to  show a rise in quarterly revenue when it reports  results ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nL8N3TX31L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON"],"gpt_icon":0},{"id":"2550522721","title":"REFILE-BUZZ-U.S. STOCKS ON THE MOVE-BTCS, BrainStorm Cell, Moderna","url":"https://stock-news.laohu8.com/highlight/detail?id=2550522721","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550522721?lang=en_us&edition=fundamental","pubTime":"2025-07-09 01:53","pubTimestamp":1751997200,"startTime":"0","endTime":"0","summary":"REFILE-BUZZ-U.S. STOCKS ON THE MOVE-BTCS, BrainStorm Cell, ModernaRefiles to add 'compiled by' credentialsEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nL6N3T50GA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGNY","IE00BN0W2V16.EUR","HON","ETON","ENPH","LU1150488135.SGD","LU1429558221.USD","NEXT","UNP","CTVA","AMRC","TBBK","SCCO","GFS","FCX","CSX","MRNA","DUOL","WW","BAC","APA","LNG","LU0496365809.HKD","CIEN","LU2237438978.USD","NNE","BCLI","BTCS","NOC","NEM","HSY","CRGX","COP","FICO","XOM","NSC","DVN","GD","FSLR","LU0823414478.USD","LU0130517989.USD","SEDG","CVX","WAB"],"gpt_icon":1},{"id":"2549470365","title":"BUZZ-U.S. STOCKS ON THE MOVE-ProKidney, Eton Pharma, Datadog","url":"https://stock-news.laohu8.com/highlight/detail?id=2549470365","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549470365?lang=en_us&edition=fundamental","pubTime":"2025-07-08 21:06","pubTimestamp":1751979961,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-ProKidney, Eton Pharma, DatadogEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: ht","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nL6N3T50G9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNP","BK4561","LU0061475181.USD","NSC","SG9999015358.SGD","DDOG","CTVA","BHP.AU","LU2505996681.GBP","BK4588","LU0203347892.USD","LU2471134879.HKD","FCX","CON","LU1582987597.SGD","XOM","BK4581","LU2211815571.USD","LU2471134796.USD","LU0889566641.SGD","ETON","BAC","PROK","FSLR","WW","LU2602419157.SGD","LU2264538146.SGD","RIO.UK","LIF","LU0082616367.USD","LU0306806265.USD","LU1548497426.USD","LU0310800379.SGD","LU0823421333.USD","SEDG","CRGX","LU1267930573.SGD","SCCO","IE00BLSP4452.SGD","CCJ","LU2275660780.HKD","LU0208291251.USD","LU0302445910.USD","LU1582986433.USD","LU0048573561.USD","CSX","RIO.AU","ENPH"],"gpt_icon":1},{"id":"2549554402","title":"BUZZ-Eton Pharma rises after US FDA accepts application for hormone disorder drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2549554402","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549554402?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:13","pubTimestamp":1751976807,"startTime":"0","endTime":"0","summary":"BUZZ-Eton Pharma rises after US FDA accepts application for hormone disorder drug** Shares of drugmaker Eton Pharmaceuticals ETON.O rise 3.5% to $14.90 premarket** Co says the US FDA has accepted its application for potential approval of its drug candidate ET-600** If approved, ET-600 is expected to be the only oral liquid option on the market for central diabetes insipidius, ETON says** Central diabetes insipidius is a condition where the body doesn't produce enough vasopressin, a hormone that regulates water balance by signaling kidneys to conserve water** The FDA will give its decision on ET-600 on or before February 26, 2026** Up to last close, stock had risen 8% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nL6N3T50JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"gpt_icon":0},{"id":"2549541880","title":"BRIEF-Eton Pharmaceuticals Announces FDA Acceptance Of New Drug Application For Et-600","url":"https://stock-news.laohu8.com/highlight/detail?id=2549541880","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549541880?lang=en_us&edition=fundamental","pubTime":"2025-07-08 19:25","pubTimestamp":1751973901,"startTime":"0","endTime":"0","summary":"BRIEF-Eton Pharmaceuticals Announces FDA Acceptance Of New Drug Application For Et-600July 8 (Reuters) - Eton Pharmaceuticals Inc ETON.O:ETON PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nTUA5YFBFW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"gpt_icon":0},{"id":"2549546236","title":"Eton Pharmaceuticals Announces FDA Acceptance of NDA for ET-600 Desmopressin Oral Solution, Target Action Date Set for February 25, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2549546236","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549546236?lang=en_us&edition=fundamental","pubTime":"2025-07-08 18:50","pubTimestamp":1751971810,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals Announces FDA Acceptance of NDA for ET-600 Desmopressin Oral Solution, Target Action Date Set for February 25, 2026. Eton Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration  has accepted their New Drug Application  for ET-600, a proprietary patented formulation of desmopressin oral solution. This development marks a significant step forward in the regulatory review process, with the FDA assigning a Prescription Drug User Fee Act  target action date of February 25, 2026. If approved, ET-600 will be the only oral liquid option available on the market to deliver precise doses for pediatric patients. The product has patent protection through 2044, and Eton is preparing for a potential launch in the first quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nNDL9rsP6j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4112","LU2210149790.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","NDAQ","IE00BKPKM429.USD","BK4007","ETON","BK4588","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.etonpharma.com","stockEarnings":[{"period":"1week","weight":0.0271},{"period":"1month","weight":-0.0435},{"period":"3month","weight":-0.0538},{"period":"6month","weight":0.1678},{"period":"1year","weight":0.3734},{"period":"ytd","weight":0.2538}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.072708},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.010272},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.063788},{"month":4,"riseRate":0.428571,"avgChangeRate":0.050454},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.015801},{"month":6,"riseRate":0.142857,"avgChangeRate":-0.077586},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.03574},{"month":8,"riseRate":0.714286,"avgChangeRate":0.150873},{"month":9,"riseRate":0.571429,"avgChangeRate":0.07288},{"month":10,"riseRate":0.571429,"avgChangeRate":0.067693},{"month":11,"riseRate":0.571429,"avgChangeRate":0.051311},{"month":12,"riseRate":0.625,"avgChangeRate":0.050288}],"exchange":"NASDAQ","name":"Eton Pharmaceuticals, Inc.","nameEN":"Eton Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Eton Pharmaceuticals, Inc.(ETON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Eton Pharmaceuticals, Inc.(ETON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Eton Pharmaceuticals, Inc.,ETON,Eton Pharmaceuticals, Inc.股票,Eton Pharmaceuticals, Inc.股票老虎,Eton Pharmaceuticals, Inc.股票老虎国际,Eton Pharmaceuticals, Inc.行情,Eton Pharmaceuticals, Inc.股票行情,Eton Pharmaceuticals, Inc.股价,Eton Pharmaceuticals, Inc.股市,Eton Pharmaceuticals, Inc.股票价格,Eton Pharmaceuticals, Inc.股票交易,Eton Pharmaceuticals, Inc.股票购买,Eton Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Eton Pharmaceuticals, Inc.(ETON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Eton Pharmaceuticals, Inc.(ETON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction